Back to GetFilings.com



 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended September 30, 2002

 

 

o

TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                to               

 

Commission File Number: 1-12624

 

Syratech Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

13-3354944

(State or other jurisdiction
of incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

175 McClellan Highway
East Boston, Massachusetts

 

02128-9114

(Address of  principal executive office)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code - 617-561-2200

 

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  o  NO  ý

 

Number of Shares of Common Stock, Par Value $0.01 per share, outstanding at September 30, 2002- 3,784,018

 

 



 

INDEX

 

PART I - FINANCIAL INFORMATION

 

 

Item 1.

Financial Statements:

 

 

 

Condensed Consolidated Balance Sheets at September 30, 2002 and December 31, 2001

 

 

 

Condensed Consolidated Income Statements for the three and nine month periods ended September 30, 2002 and 2001

 

 

 

Condensed Consolidated Statements of Cash Flows for the nine month periods ended September 30, 2002 and 2001

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4.

Controls and Procedures

 

 

PART II - OTHER INFORMATION

 

 

Item 5.

Other information

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

Signature

 

 

 

Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 



 

PART 1 - FINANCIAL INFORMATION

 

ITEM 1. Financial Statements

 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in thousands, except share data)

 

 

 

September 30,
2002

 

December 31,
2001

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and equivalents

 

$

860

 

$

5,242

 

Accounts receivable, net

 

67,651

 

57,530

 

Inventories 

 

99,141

 

74,949

 

Deferred income taxes

 

15,225

 

17,848

 

Prepaid expenses and other

 

3,193

 

2,665

 

Total current assets

 

186,070

 

158,234

 

 

 

 

 

 

 

Property, plant and equipment, net

 

64,444

 

68,195

 

Purchase price in excess of net assets acquired, net

 

 

6,225

 

Other assets, net

 

3,972

 

4,717

 

Total

 

$

254,486

 

$

237,371

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Revolving loan facilities and notes payable

 

$

38,263

 

$

16,995

 

Accounts payable

 

23,173

 

10,976

 

Accrued expenses

 

7,184

 

8,079

 

Accrued interest

 

7,582

 

4,359

 

Accrued compensation

 

2,402

 

4,181

 

Accrued advertising

 

3,567

 

3,263

 

Income taxes payable

 

1,277

 

129

 

Total current liabilities

 

83,448

 

47,982

 

 

 

 

 

 

 

Long-term debt

 

155,031

 

157,634

 

Deferred income taxes

 

18,818

 

18,818

 

Pension liability

 

2,564

 

2,809

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value, 500,000 shares authorized; (25,000 designated as cumulative redeemable preferred stock, 18,000 shares issued and outstanding, liquidation value of $18,000, and includes accrued and unpaid dividends of $15,496 and $12,731 in 2002 and 2001, respectively)

 

33,496

 

30,731

 

Common stock, $.01 par value, 20,000,000 shares authorized; 3,784,018 shares issued and outstanding

 

38

 

38

 

Deficit

 

(37,861

)

(19,092

)

Accumulated other comprehensive loss

 

(1,048

)

(1,549

)

Total stockholders’ equity

 

(5,375

)

10,128

 

Total

 

$

254,486

 

$

237,371

 

 

See notes to consolidated financial statements.

 

1



 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except per share data)

 

 

 

Three Months
Ended September 30,

 

Nine Months
Ended September 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

97,232

 

$

104,008

 

$

177,934

 

$

186,285

 

Cost of sales

 

69,909

 

73,663

 

127,843

 

133,879

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

27,323

 

30,345

 

50,091

 

52,406

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

18,070

 

18,037

 

49,087

 

49,853

 

Other operating income

 

 

455

 

1,236

 

1,231

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

9,253

 

12,763

 

2,240

 

3,784

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(5,192

)

(5,826

)

(15,278

)

(16,544

)

Interest income

 

1

 

23

 

1

 

29

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before provision (benefit) for income taxes and cumulative effect of a change in accounting principle

 

4,062

 

6,960

 

(13,037

)

(12,731

)